105 related articles for article (PubMed ID: 1629751)
21. Synthesis and biological activity of novel ester derivatives of N(3)-(4-metoxyfumaroyl)-(S)-2,3-diaminopropanoic acid containing amide and keto function as inhibitors of glucosamine-6-phosphate synthase.
Pawlak D; Schielmann M; Wojciechowski M; Andruszkiewicz R
Bioorg Med Chem Lett; 2016 Aug; 26(15):3586-9. PubMed ID: 27324977
[TBL] [Abstract][Full Text] [Related]
22. The influence of L-norvalyl-N3-4-methoxyfumaroyl-L-2,3-diaminopropanoic acid, an antifungal agent, on mammalian cells in tissue culture.
Bontemps-Gracz M; Milewski S; Borowski E
Acta Biochim Pol; 1991; 38(2):229-39. PubMed ID: 1814130
[TBL] [Abstract][Full Text] [Related]
23. Emerging Anticancer Activity of Candidal Glucoseamine-6-Phosphate Synthase Inhibitors upon Nanoparticle-Mediated Delivery.
Kertmen A; Przysiecka Ł; Coy E; Popenda Ł; Andruszkiewicz R; Jurga S; Milewski S
Langmuir; 2019 Apr; 35(15):5281-5293. PubMed ID: 30912436
[TBL] [Abstract][Full Text] [Related]
24. Antihistoplasmal in vitro and in vivo effect of Lys-Nva-FMDP.
Milewski S; Mignini F; Micossi L; Borowski E
Med Mycol; 1998 Jun; 36(3):177-80. PubMed ID: 9776831
[TBL] [Abstract][Full Text] [Related]
25. Synthetic derivatives of N3-fumaroyl-L-2,3-diaminopropanoic acid inactivate glucosamine synthetase from Candida albicans.
Milewski S; Chmara H; Andruszkiewicz R; Borowski E
Biochim Biophys Acta; 1985 Apr; 828(3):247-54. PubMed ID: 3921053
[TBL] [Abstract][Full Text] [Related]
26. Glucosamine synthetase from Escherichia coli: kinetic mechanism and inhibition by N3-fumaroyl-L-2,3-diaminopropionic derivatives.
Badet B; Vermoote P; Le Goffic F
Biochemistry; 1988 Apr; 27(7):2282-7. PubMed ID: 3132968
[TBL] [Abstract][Full Text] [Related]
27. Glucosamine-6-phosphate synthase from Escherichia coli: determination of the mechanism of inactivation by N3-fumaroyl-L-2,3-diaminopropionic derivatives.
Kucharczyk N; Denisot MA; Le Goffic F; Badet B
Biochemistry; 1990 Apr; 29(15):3668-76. PubMed ID: 2111163
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide analysis of PTR transporters in Candida species and their functional characterization in Candida auris.
Khatoon R; Sharma S; Prasad R; Lynn AM; Prakash A; Banerjee A
Appl Microbiol Biotechnol; 2022 Jun; 106(11):4223-4235. PubMed ID: 35648145
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of glucosamine-6-phosphate synthetase from Salmonella typhimurium LT2 by fumaroyl diaminopropanoic acid derivatives, a novel group of glutamine analogs.
Chmara H; Andruszkiewicz R; Borowski E
Biochim Biophys Acta; 1986 Mar; 870(2):357-66. PubMed ID: 3082365
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of N3-fumaramoyl-L-2,3-diaminopropanoic acid analogues, the irreversible inhibitors of glucosamine synthetase.
Andruszkiewicz R; Chmara H; Milewski S; Borowski E
Int J Pept Protein Res; 1986 May; 27(5):449-53. PubMed ID: 3089958
[TBL] [Abstract][Full Text] [Related]
31. Fluconazole resistant
Shahi G; Kumar M; Skwarecki AS; Edmondson M; Banerjee A; Usher J; Gow NAR; Milewski S; Prasad R
Cell Surf; 2022 Dec; 8():100076. PubMed ID: 35252632
[TBL] [Abstract][Full Text] [Related]
32. Transport Deficiency Is the Molecular Basis of
Schielmann M; Szweda P; Gucwa K; Kawczyński M; Milewska MJ; Martynow D; Morschhäuser J; Milewski S
Front Microbiol; 2017; 8():2154. PubMed ID: 29163437
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial properties of N3-(iodoacetyl)-L-2,3-diaminopropanoic acid-peptide conjugates.
Andruszkiewicz R; Chmara H; Milewski S; Zieniawa T; Borowski E
J Med Chem; 1990 Oct; 33(10):2755-9. PubMed ID: 2120441
[TBL] [Abstract][Full Text] [Related]
34. N3-haloacetyl derivatives of L-2,3-diaminopropanoic acid: novel inactivators of glucosamine-6-phosphate synthase.
Milewski S; Chmara H; Andruszkiewicz R; Borowski E
Biochim Biophys Acta; 1992 Jan; 1115(3):225-9. PubMed ID: 1739736
[TBL] [Abstract][Full Text] [Related]
35. Anticandidal activity of antibiotic A 19009 and its isomer.
Andruszkiewicz R; Chmara H; Borowski E
J Antibiot (Tokyo); 1984 Nov; 37(11):1479-82. PubMed ID: 6392271
[No Abstract] [Full Text] [Related]
36. Structure-activity relationships for a series of peptidomimetic antimicrobial prodrugs containing glutamine analogues.
Marshall NJ; Andruszkiewicz R; Gupta S; Milewski S; Payne JW
J Antimicrob Chemother; 2003 Apr; 51(4):821-31. PubMed ID: 12654735
[TBL] [Abstract][Full Text] [Related]
37. Effect of antifungal agents on the binding of Candida albicans to immobilized amino acids and bovine serum albumin.
Islam K; Hawser SP
J Antimicrob Chemother; 1999 Apr; 43(4):583-7. PubMed ID: 10350392
[TBL] [Abstract][Full Text] [Related]
38. Influence of human serum on antifungal pharmacodynamics with Candida albicans.
Zhanel GG; Saunders DG; Hoban DJ; Karlowsky JA
Antimicrob Agents Chemother; 2001 Jul; 45(7):2018-22. PubMed ID: 11408217
[TBL] [Abstract][Full Text] [Related]
39. Sporothrix schenckii: purification and partial biochemical characterization of glucosamine-6-phosphate synthase, a potential antifungal target.
González-Ibarra J; Milewski S; Villagómez-Castro JC; Cano-Canchola C; López-Romero E
Med Mycol; 2010 Feb; 48(1):110-21. PubMed ID: 19353425
[TBL] [Abstract][Full Text] [Related]
40. Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5.
Rothstein DM; Spacciapoli P; Tran LT; Xu T; Roberts FD; Dalla Serra M; Buxton DK; Oppenheim FG; Friden P
Antimicrob Agents Chemother; 2001 May; 45(5):1367-73. PubMed ID: 11302797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
